Merit Medical Systems Receivables 2010-2024 | MMSI

Merit Medical Systems receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
  • Merit Medical Systems receivables for the quarter ending September 30, 2024 were $0.218B, a 11.7% increase year-over-year.
  • Merit Medical Systems receivables for 2023 were $0.193B, a 5.99% increase from 2022.
  • Merit Medical Systems receivables for 2022 were $0.182B, a 3.38% increase from 2021.
  • Merit Medical Systems receivables for 2021 were $0.176B, a 9.12% increase from 2020.
Merit Medical Systems Annual Receivables
(Millions of US $)
2023 $193
2022 $182
2021 $176
2020 $162
2019 $172
2018 $154
2017 $119
2016 $89
2015 $81
2014 $82
2013 $65
2012 $59
2011 $46
2010 $41
2009 $33
Merit Medical Systems Quarterly Receivables
(Millions of US $)
2024-09-30 $218
2024-06-30 $201
2024-03-31 $196
2023-12-31 $193
2023-09-30 $195
2023-06-30 $192
2023-03-31 $190
2022-12-31 $182
2022-09-30 $174
2022-06-30 $173
2022-03-31 $173
2021-12-31 $176
2021-09-30 $168
2021-06-30 $169
2021-03-31 $166
2020-12-31 $162
2020-09-30 $165
2020-06-30 $161
2020-03-31 $168
2019-12-31 $172
2019-09-30 $170
2019-06-30 $176
2019-03-31 $162
2018-12-31 $154
2018-09-30 $143
2018-06-30 $146
2018-03-31 $133
2017-12-31 $119
2017-09-30 $110
2017-06-30 $112
2017-03-31 $104
2016-12-31 $89
2016-09-30 $87
2016-06-30 $85
2016-03-31 $81
2015-12-31 $81
2015-09-30 $76
2015-06-30 $76
2015-03-31 $78
2014-12-31 $82
2014-09-30 $75
2014-06-30 $73
2014-03-31 $69
2013-12-31 $65
2013-09-30 $62
2013-06-30 $63
2013-03-31 $60
2012-12-31 $59
2012-09-30 $53
2012-06-30 $52
2012-03-31 $51
2011-12-31 $46
2011-09-30 $43
2011-06-30 $44
2011-03-31 $43
2010-12-31 $41
2010-09-30 $41
2010-06-30 $38
2010-03-31 $36
2009-12-31 $33
2009-09-30 $33
2009-06-30 $32
2009-03-31 $31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.988B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.492B 21.23
Becton Dickinson (BDX) United States $66.954B 17.60
Cardinal Health (CAH) United States $29.177B 15.82
West Pharmaceutical Services (WST) United States $23.472B 47.94
Cooper (COO) United States $20.662B 29.41
Labcorp (LH) United States $20.273B 16.81
Align Technology (ALGN) United States $16.462B 31.50
Henry Schein (HSIC) United States $8.478B 16.15
DENTSPLY SIRONA (XRAY) United States $3.620B 9.65
CONMED (CNMD) United States $2.268B 18.93
Patterson (PDCO) United States $1.833B 9.67
STAAR Surgical (STAA) United States $1.458B 53.80
Lifevantage (LFVN) United States $0.171B 22.77
Pro-Dex (PDEX) United States $0.139B 27.71